Siemens Healthineers: stock slips slightly after first resul
(CercleFinance.com) - Floated on the stockmarket in March at a benchmark price of 28 euros, the Siemens Healthineers share is down 1.
5% today after its first results publication, underperforming the DAX 30, which is down just 0.2%.
However, the stock has risen by over 15% since its IPO.
In Q1 2018, Siemens' medical equipment subsidiary posted a 5% decline in published sales at 3.2 billion euros. FX factors weighed heavily (-9 percentage points), as on a like-for-like basis, growth reached 4%. The medical imaging division, which represents approximately 60% of sales and an even greater proportion of results, reported organic growth of 6%.
Operating income fell by 16% to 457 million euros, due to extraordinary items, including IPO costs (non-recurrent). However, in adjusted terms, the group's margin increased from 16.5% to 17.4%. Finally, reported earnings rose inched up just 1% to 308 million euros, while in adjusted terms, they rose by 26% to 428 million euros.
Finally, Siemens Healthineers' CEO Bernd Montag has confirmed the group's forecasts, which includes organic growth of 3% to 4% for the year ending in September, with an adjusted operating margin of between 17% and 18%.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
5% today after its first results publication, underperforming the DAX 30, which is down just 0.2%.
However, the stock has risen by over 15% since its IPO.
In Q1 2018, Siemens' medical equipment subsidiary posted a 5% decline in published sales at 3.2 billion euros. FX factors weighed heavily (-9 percentage points), as on a like-for-like basis, growth reached 4%. The medical imaging division, which represents approximately 60% of sales and an even greater proportion of results, reported organic growth of 6%.
Operating income fell by 16% to 457 million euros, due to extraordinary items, including IPO costs (non-recurrent). However, in adjusted terms, the group's margin increased from 16.5% to 17.4%. Finally, reported earnings rose inched up just 1% to 308 million euros, while in adjusted terms, they rose by 26% to 428 million euros.
Finally, Siemens Healthineers' CEO Bernd Montag has confirmed the group's forecasts, which includes organic growth of 3% to 4% for the year ending in September, with an adjusted operating margin of between 17% and 18%.
Copyright (c) 2018 CercleFinance.com. All rights reserved.